Schroder Investment Management Group
VERA icon

Schroder Investment Management Group’s Vera Therapeutics VERA Stock Holding History

Schroder Investment Management Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Buy
510,787
+26,406
+5% +$984K 0.02% 530
2026
Q1 		$18.5M Buy
484,381
+452,602
+1,424% +$19.5M 0.02% 545
2025
Q4 		$1.63M Sell
31,779
-648,213
-95% -$23M ﹤0.01% 916
2025
Q3 		$19.7M Buy
679,992
+307,243
+82% +$7.11M 0.02% 532
2025
Q2 		$8.78M Sell
372,749
-86,092
-19% -$1.94M 0.01% 658
2025
Q1 		$12.2M Sell
458,841
-26,304
-5% -$845K 0.01% 605
2024
Q4 		$20.4M Buy
485,145
+8,432
+2% +$373K 0.02% 508
2024
Q3 		$20.7M Buy
476,713
+43,541
+10% +$1.65M 0.02% 504
2024
Q2 		$15.7M Buy
433,172
+81,519
+23% +$3.23M 0.02% 531
2024
Q1 		$15.2M Sell
351,653
-759,307
-68% -$27.1M 0.02% 556
2023
Q4 		$17.1M Buy
+1,110,960
New +$14.1M 0.02% 520

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Schroder Investment Management Group's VERA Position: Q2 2026 in Review

Schroder Investment Management Group increased its Vera Therapeutics (VERA) stake by 5.5% in Q2 2026, buying an estimated $984K and bringing the position to 510,787 shares worth $22M. The position accounts for 0.02% of the portfolio, ranked #530.

Schroder Investment Management Group first reported a position in VERA in Q4 2023 and has held it in 11 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Schroder Investment Management Group held 510,787 shares of Vera Therapeutics worth $22M as of Q2 2026.
  • Schroder Investment Management Group bought 26,406 Vera Therapeutics shares in Q2 2026, an estimated $984K.
  • Vera Therapeutics made up 0.02% of Schroder Investment Management Group's portfolio in Q2 2026, its #530 holding.
  • Schroder Investment Management Group first reported a position in Vera Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.